Jane Foo
Impact in
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- SARS-CoV-2 detection and testing
- Neurology top 5%
- Long-Term Effects of COVID-19
Papers in
-
- SARS-CoV-2 and COVID-19 Research 2
-
- Protein Degradation and Inhibitors 1
- RNA Research and Splicing 1
- Hedgehog Signaling Pathway Studies 1
- Genomics and Chromatin Dynamics 1
- RNA and protein synthesis mechanisms 1
- Ubiquitin and proteasome pathways 1
- Co-authors
- Na Li (2 shared papers)Mannan Nouri (2 shared papers)Ralph E. Buttyan (2 shared papers)Brett G. Hollier (1 shared paper)Xuesen Dong (1 shared paper)Colin C. Collins (1 shared paper)Martin Edwin Gleave (1 shared paper)Amy Anne Lubik (1 shared paper)
- Journals
- The Lancet (5 papers)Molecular and Cellular Endocrinology (1 paper)International Journal of Molecular Sciences (1 paper)Breast Cancer Research (1 paper)Nature Communications (1 paper)
- Partner nations
- CanadaUnited KingdomAustralia
In The Last Decade
Jane Foo
10 papers receiving 1.3k citations
Jane Foo's Hit Papers
Peers
Comparison fields: 5 of 101
- Infectious Diseases 728
- Neurology 251
- Internal Medicine 54
- Obstetrics and Gynecology 69
- Critical Care and Intensive Care Medicine 34
Countries citing papers authored by Jane Foo
This map shows the geographic impact of Jane Foo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane Foo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane Foo more than expected).
Fields of papers citing papers by Jane Foo
This network shows the impact of papers produced by Jane Foo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane Foo. The network helps show where Jane Foo may publish in the future.
Co-authors
The 25 scholars most cited alongside Jane Foo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Hit paper breakdown → | 2021 | 381 |
| 2 | Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2022 | 282 |
| 3 | Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis Hit paper breakdown → | 2022 | 230 |
| 4 | Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 211 |
| 5 | 2023 | 83 | |
| 6 | 2022 | 66 | |
| 7 | 2020 | 32 | |
| 8 | 2022 | 12 | |
| 9 | 2020 | 10 | |
| 10 | 2024 | 3 | |
| 11 | 2025 | 0 |
About Jane Foo
Jane Foo is a scholar working on Infectious Diseases, Molecular Biology, Computational Theory and Mathematics, Oncology and Genetics, having authored 11 papers that have together received 1.3k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (2 papers), Computational Drug Discovery Methods (1 paper), Protein Degradation and Inhibitors (1 paper), RNA Research and Splicing (1 paper), Hedgehog Signaling Pathway Studies (1 paper), Genomics and Chromatin Dynamics (1 paper), RNA and protein synthesis mechanisms (1 paper) and Ubiquitin and proteasome pathways (1 paper). The work is most often cited by research in Infectious Diseases (728 citations), Neurology (251 citations), Internal Medicine (54 citations), Obstetrics and Gynecology (69 citations) and Critical Care and Intensive Care Medicine (34 citations). Jane Foo has collaborated with scholars based in Canada, United Kingdom and Australia. Frequent co-authors include Na Li, Mannan Nouri, Ralph E. Buttyan, Brett G. Hollier, Xuesen Dong, Colin C. Collins, Martin Edwin Gleave, Amy Anne Lubik, Ladan Fazli and Ahn R. Lee. Their work appears in journals such as The Lancet, Molecular and Cellular Endocrinology, International Journal of Molecular Sciences, Breast Cancer Research and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.